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Abstract objective Previous reviews on participants’ comprehension of informed consent information have
focused on developed countries. Experience has shown that ethical standards developed on Western
values may not be appropriate for African settings where research concepts are unfamiliar. We
undertook this review to describe how informed consent comprehension is defined and measured in
African research settings.
methods We conducted a comprehensive search involving five electronic databases: Medline,
Embase, Global Health, EthxWeb and Bioethics Literature Database (BELIT). We also examined
African Index Medicus and Google Scholar for relevant publications on informed consent
comprehension in clinical studies conducted in sub-Saharan Africa. 29 studies satisfied the inclusion
criteria; meta-analysis was possible in 21 studies. We further conducted a direct comparison of
participants’ comprehension on domains of informed consent in all eligible studies.
results Comprehension of key concepts of informed consent varies considerably from country to
country and depends on the nature and complexity of the study. Meta-analysis showed that 47% of a
total of 1633 participants across four studies demonstrated comprehension about randomisation
(95% CI 13.9–80.9%). Similarly, 48% of 3946 participants in six studies had understanding about
placebo (95% CI 19.0–77.5%), while only 30% of 753 participants in five studies understood the
concept of therapeutic misconception (95% CI 4.6–66.7%). Measurement tools for informed consent
comprehension were developed with little or no validation. Assessment of comprehension was carried
out at variable times after disclosure of study information. No uniform definition of informed consent
comprehension exists to form the basis for development of an appropriate tool to measure
comprehension in African participants.
conclusions Comprehension of key concepts of informed consent is poor among study participants
across Africa. There is a vital need to develop a uniform definition for informed consent
comprehension in low literacy research settings in Africa. This will be an essential step towards
developing appropriate tools that can adequately measure informed consent comprehension. This may
consequently suggest adequate measures to improve the informed consent procedure.
keywords informed consent, understanding, Africa, vulnerable population, systematic review
Introduction
Comprehension is one of the essential elements of a truly
informed consent. International ethical guidelines stipulate
that informed consent must be given in a comprehensible
manner to a competent person who freely decides to par-
ticipate after understanding the information (NBAC 2001;
CIOMS 2002; Marshall 2006). However, the amount and
quality of study information required to engender
comprehension of a potential participant is unclear. There
are also divergent opinions among researchers on the level
of comprehension a potential participant should reach to
be able to freely decide (Ijsselmuiden & Faden 1992;
Hyder & Wali 2006). In most African settings, the major-
ity of research participants have low literacy, but informed
consent documents are designed and delivered in a com-
plex, lengthy manner that makes comprehension very
challenging for the participants (Priestley et al. 1992;
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Jefford & Moore 2008; Falagas et al. 2009). In such set-
tings, what constitutes ‘satisfactory or adequate’ compre-
hension of informed consent is vague (Sreenivasan 2003;
Woodsong & Karim 2005). This phenomenon has raised
concerns about the quality and ethics of data generated
from the increasing number of clinical trials being con-
ducted in these low literacy communities (Annas 2009).
A previous review of studies conducted in developed
countries reported a lack of consensus definition of compre-
hension and an absence of a standardised tool to measure
objectively the adequacy of participants’ comprehension
(Sand et al. 2010). The authors concluded that a contextual
definition of comprehension and systematic design of an
instrument could guarantee adequate measurement of par-
ticipants’ comprehension (Sand et al. 2010; Mandava et al.
2012). This underscores the need to contextualise the defi-
nition of comprehension of informed consent information
for different research settings as this may inform the devel-
opment of a locally acceptable, culturally sensitive measure
of informed consent comprehension.
We undertook this review to examine how participants’
comprehension of informed consent information has been
defined and measured in clinical studies conducted in sub-
Saharan Africa (SSA). This will be a major step towards
reaching a consensus definition of informed consent com-
prehension in African research settings, which in turn will
help to design improved informed consent procedures.
Methods
Literature search strategy
We searched five electronic databases for empirical stud-
ies on comprehension levels of different domains of
informed consent among participants in SSA. The data-
bases were Embase (1947–2010), Medline (1960–2010),
Global Health (1960–2010), EthxWeb and Bioethics Lit-
erature Database (BELIT). To complement these databas-
es, we also searched African Index Medicus (AIM) and
Google Scholar for relevant bibliographies and grey liter-
ature. The last search was conducted on 11 October
2013. Studies were included if they satisfied the following
three criteria:
• assessed or evaluated participants’ comprehension of
informed consent information;
• involved participants who were in clinical studies
rather than hypothetical trials;
• were conducted in a SSA country.
The initial search was conducted on Ovid MEDLINE
using a combination of medical subject headings (MeSH)
and text words and then translated into the terms
appropriate to Ovid Embase, Ovid Global Health, Ethx-
Web and BELIT. The AIM and Google scholar databases
were also searched using text words. The search terms
included (informed consent OR consent OR informed
decision) AND (understanding OR comprehension OR
retention OR knowledge OR awareness OR recall) AND
(clinical trials OR clinical research OR randomi٭ed clini-
cal trials). ‘Sub-Saharan Africa’ was searched using Africa
south of Sahara OR developing countries OR low-income
countries OR vulnerable population OR underserved
population. To ensure all relevant countries were
included in the review, sub-Saharan African countries
listed in World RePORT database of global research
(Collins et al. 2013) were used as a guide. Furthermore,
to ensure the search was not limited to English language
studies, specific Francophone and Lusophone country
names such as Angola, Burkina Faso, Cape Verde, Cote
d’Ivoire, Gabon, Guinea-Bissau, Mali, Mozambique, Sao
Tome and Principe and Senegal were also included in the
search terms. Specific search algorithms used in each
database are presented in Table 1.
Duplicate results from the searches were removed, and
thereafter, the abstracts of retrieved articles were reviewed
for relevance prior to accessing the full paper. We excluded
letters or responses to published articles, commentaries
and editorials. Conference abstracts that had not been
published as full papers were included where the abstracts
could be retrieved, provided that the abstracts had suffi-
cient information for either qualitative or quantitative
analysis. In situations where a conference abstract had
been published as a full paper, the paper was retrieved and
the conference abstract excluded. We contacted authors of
conference abstracts whose full-paper publications could
not be accessed to ask whether the abstract had been pub-
lished as a full paper and if not, to seek more information
about the study. Of five authors contacted, only one
responded by providing the full text paper of the confer-
ence abstract. However, the published article provided by
the author (Ravinetto et al. 2010) did not meet the eligibil-
ity criteria and was not included in the final analysis.
Data extraction
We obtained 245 articles from the primary search and 64
articles from AIM and Google scholar. Two of the review
authors (MOA and JUO) independently screened the
searches and applied the eligibility criteria. Of these 309
articles, 192 were removed because they were duplicates.
Another 88 articles were sequentially excluded for the rea-
sons of ineligibility. 29 studies satisfied the three inclusion
criteria and were reviewed in detail. Figure 1 illustrates
the inclusion process. Twenty-three of the studies were
626 © 2014 John Wiley & Sons Ltd
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conducted in Anglophone countries (Abdool Karim et al.
1998; Leach et al. 1999; Joubert et al. 2003; Molyneux
et al. 2004; Moodley et al. 2005; Pace et al. 2005; Mar-
shall et al. 2006; Manafa et al. 2007; Hill et al. 2008;
Minnies et al. 2008; Oduro et al. 2008; Taiwo & Kass
2009; Tekola et al. 2009; Vallely et al. 2010; Chaisson
et al. 2011; Friedland et al., 2011a,b; Hussein & Ahmed
2011; Kiguba et al. 2012; Ndebele et al. 2012; Vreeman
et al. 2012; Oria et al. 2013; Saidu et al. 2013); five in
Francophone countries (Preziosi et al. 1997; Coulibaly-
Traore et al. 2003; Ekouevi et al. 2004; Krosin et al.
2006; Ellis et al. 2010) and one in a Lusophone country
(Ciampa et al. 2012). Similarly, 12 of these studies were
conducted in West Africa (Preziosi et al. 1997; Leach
et al. 1999; Coulibaly-Traore et al. 2003; Ekouevi et al.
2004; Krosin et al. 2006; Marshall et al. 2006; Manafa
et al. 2007; Hill et al. 2008; Oduro et al. 2008; Taiwo &
Kass 2009; Ellis et al. 2010; Saidu et al. 2013), eight in
East Africa (Molyneux et al. 2004; Pace et al. 2005;
Tekola et al. 2009; Vallely et al. 2010; Hussein & Ahmed
2011; Kiguba et al. 2012; Vreeman et al. 2012; Oria
et al. 2013) and nine in Southern Africa (Abdool Karim
et al. 1998; Joubert et al. 2003; Moodley et al. 2005;
Minnies et al. 2008; Chaisson et al. 2011; Friedland
et al., 2011a,b; Ciampa et al. 2012; Ndebele et al. 2012).
Despite adoption of official languages of former colonial
masters, countries in each subregion share similar socio-
cultural factors that may influence informed consent com-
prehension (Angell 1997; Annas 2009). Therefore, this
review focused on a regional comparison rather than the
adopted official languages.
We extracted information on the type and sites of the
studies, the sample size, definition of understanding/com-
prehension as provided by the authors, method and tim-
ing of evaluation of participants’ comprehension. Also
retrieved were data on participants’ understanding/com-
prehension of study information including key concepts
of informed consent: study nature and purpose, blinding,
placebo, randomisation, voluntariness, rights of with-
drawal, benefits/risks and adverse events. We performed
Table 1 Search strategy for the systematic review
Concept Search terms
EMBASE via
Ovid
(1947–2013)
Global Health
via Ovid
(1910–2013)
Medline via
Ovid
(1946–2013) EthxWeb
BELIT via
DRZE
(1850–2013)
Informed
consent
#1: (informed consent OR consent
OR informed decision). mp.
319882 10179 164307 22586 59923
Comprehension #2: (understanding OR
comprehension OR retention OR
knowledge OR awareness OR
recall). mp.
1318519 158692 662692 880 9630
Clinical
research
#3: (biomedical research OR clinical
research OR clinical trials OR
randomi*ed controlled clinical trials
OR random allocation trials OR
intervention trials). mp.
275353 25182 363991 50885 117927
sub-Saharan
Africa
#4: (Africa south of Sahara OR low-
income countr* OR developing
countr* OR vulnerable populations
OR disadvantaged populations OR
underserved populations).mp. exp
Angola/ OR exp Burkina Faso/ OR
exp Cape Verde/ OR exp Cote
d’Ivoire/OR exp Gabon/ OR exp
Guinea-Bissau/OR exp Mali
Mozambique/ OR exp Sao Tome
and Principe/ OR exp Senegal. mp.
107234 610100 103689 189847 373209
All #1 AND #2 AND #3 AND #4 74 27 104 36 4
BELIT – Bioethics Literature Database: extensive bibliographic directory of literature in the area of bioethics, containing monographs,
academic dissertations, collective works, reference works, books, journal articles, newspaper articles, legal documents, grey literature
and electronic document. EthxWeb – Bioethics Research Library at Georgetown University, USA, Medline mp: [mp=title, abstract,
original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept, rare disease
supplementary concept, unique identifier], Embase mp: [mp=title, subject headings, heading word, drug name, original title, device
manufacturer, drug manufacturer, device trade name, keyword].
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a detailed descriptive analysis and head-to-head
comparison of study design, timing of informed consent,
categories of participants recruited, instruments used for
assessments and domains of informed consent assessed in
each study (see Table 2).
Because only three authors provided a full question-
naire in their papers (Krosin et al. 2006; Minnies et al.
2008; Ellis et al. 2010), we did not analyse the few ques-
tionnaires for data extraction. We based our comparison
on results provided in the papers included in this review.
Meta-analysis
We conducted meta-analyses of summary statistics from
21 studies (Abdool Karim et al. 1998; Joubert et al.
2003; Ekouevi et al. 2004; Moodley et al. 2005; Pace
et al. 2005; Krosin et al. 2006; Marshall et al. 2006;
Manafa et al. 2007; Minnies et al. 2008; Oduro et al.
2008; Taiwo & Kass 2009; Ellis et al. 2010; Vallely
et al. 2010; Chaisson et al. 2011; Friedland et al., 2011a,
b; Hussein & Ahmed 2011; Kiguba et al. 2012; Ndebele
et al. 2012; Oria et al. 2013; Saidu et al. 2013) which
provided comprehension or understanding levels of par-
ticipants on different domains of informed consent. Stud-
ies which used qualitative methods for assessments of
comprehension (n = 7; Preziosi et al. 1997; Leach et al.
1999; Coulibaly-Traore et al. 2003; Molyneux et al.
2004; Hill et al. 2008; Tekola et al. 2009; Vreeman et al.
2012) and one with insufficient information (Ciampa
et al. 2012) were excluded from the meta-analysis.
References (titles and abstracts) identified 
through search of 5 electronic databases 
(n = 245)
Literature from other sources i.e Google 
scholar and African Index Medicus (n = 64) 
References identified left after duplicates were removed 
(n = 117) 
 Abstracts and titles screened 
Full text articles assessed for eligibility 
(n = 30) 
Studies included in the narrativeanalysis
(n = 29)
Excluded (n = 87) Letters to editors, com-
mentaries (n = 5) Conducted in hypotheti-
cal trials (n = 15) Conducted outside sub-
Excluded: article published from confer-
ence abstract not directly assessing un-
derstanding of informed consent (n = 1)  
192 duplicates excluded
Studies included in meta-analysis
(n = 21)
Not included in meta-analysis: (n = 8)
Qualitative instruments used (n = 7) 
Comprehension estimate not provided, 
only p-value indicated (n = 1) 
Saharan Africa (n = 67) 
Figure 1 PRISMA flow chart showing inclusion process of papers for the review.
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Owing to differences in methods of outcome assessments
(understanding scores or percentages of participants who
demonstrated understanding), we generated the propor-
tions of participants who had ‘understanding’ and 95%
confidence intervals (95% CI) for each domain of
informed consent. Random effects meta-analysis was used
to pool the estimates of proportions across the studies
because heterogeneity of study participants, study designs
and assessment tools was envisaged. We estimated heter-
ogeneity statistically using I squared statistics, which is
the proportion of true heterogeneity that could be
explained by chance (Higgins et al. 2003). Expectedly, I
squared statistics revealed a substantial heterogeneity in
all domains of informed consent assessed (I2 = 98–99%,
P < 0.0001). Tables 3 and 4 summarise the meta-analytic
results. The meta-analysis was conducted using MedCalc
statistical software version 12.7.7 (MedCalc Software
bvba, Ostend, Belgium; http://www.medcalc.org, 2013).
Table 3 Meta-analytic results of studies examining comprehension of ‘generic’ domains of informed consent
Domain Studies Total sample size Proportion (%) 95% CI
Compensation (n = 3) Chaisson et al. (2011)
Oduro et al. (2008)
Krosin et al. (2006)
2428 76.2 39.0–98.5
Voluntariness (n = 8) Chaisson et al. (2011)
Oduro et al. (2008)
Krosin et al. (2006)
Taiwo et al. (2009)
Kiguba et al. (2012)
Moodley et al. (2005)
Joubert et al. (2003)
Abdool Karim et al. (1998)
3679 78.6 63.1–90.8
Right of withdrawal (n = 13) Ekhuoevi et al. (2004)
Oduro et al. (2008)
Saidu et al. (2013)
Krosin et al. (2006)
Ellis et al. (2010)
Abdool Karim et al. (1998)
Manafa et al. (2007)
Marshall et al. (2006)
Minnies et al. (2008)
Pace et al. (2005)
Joubert et al. (2003)
Friedland et al. (2011)
Moodley et al. (2005)
4183 56.7 33.3–78.6
Right of refusal (n = 6) Ekhuoevi et al. (2004)
Manafa et al. (2007)
Kiguba et al. (2012)
Moodley et al. (2005)
Minnies et al. (2008)
Taiwo et al. (2009)
1382 48.6 25.6–71.9
Therapeutic misconception (n = 5) Ekhuoevi et al. (2004)
Krosin et al. (2006)
Taiwo et al. (2009)
Moodley et al. (2005)
Manafa et al. (2007)
753 30.1 4.6–66.7
Confidentiality (n = 4) Oduro et al. (2008)
Minnies et al. (2008)
Saidu et al. (2013)
Taiwo et al. (2009)
1775 55.4 11.1–94.7
Table shows that about 80% of study participants across the studies understood compensation and voluntariness, while only 30%
understood therapeutic misconception, 55% understood confidentiality and <60% understood right to withdraw.
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Table 4 Meta-analytic results of studies examining comprehension of ‘trial-specific’ domains of informed consent
Domains Studies
Total
sample
size
Proportion
(%)
95%
CI
Risks (n = 10) Minnies
et al. (2008)
Abdool Karim et al. (1998)
Oduro et al. (2008)
Pace et al. (2005)
Krosin et al. (2006)
Vallely et al. (2010)
Ellis et al. (2010)
Taiwo and Kass (2009)
Marshall et al. (2006)
Ndebele et al. (2012)
3419 51.3 32.1–70.2
Benefits (n = 5) Oduro et al. (2008)
Taiwo and Kass (2009)
Pace et al. (2005)
Vallely et al. (2010)
Friedland et al. (2011a,b)
2829 72.1 42.0–94.0
Placebo (n = 6) Moodley et al. (2005)
Vallely et al. (2010)
Chaisson et al. (2011)
Pace et al. (2005)
Ndebele et al. (2012)
Manafa et al. (2007)
3946 47.9 19.0–77.5
Blinding (n = 4) Chaisson et al. (2011)
Ndebele et al. (2012)
Pace et al. (2005)
Vallely et al. (2010)
3524 68.8 55.7–80.6
Randomisation (n = 4) Ellis et al. (2010)
Krosin et al. (2006)
Moodley et al. (2005)
Pace et al. (2005)
1633 46.6 13.9–80.9
Study purpose (n = 17) Saidu et al. (2013)
Minnies et al. (2008)
Abdool Karim et al. (1998)
Pace et al. (2005)
Marshall et al. (2006)
Taiwo and Kass (2009)
Krosin et al. (2006)
Joubert et al. (2003)
Ekouevi et al. (2004)
Ndebele et al. (2012)
Friedland et al. (2011a)
Friedland et al. (2011b)
Ellis et al. (2010)
Manafa et al. (2007)
Chaisson et al. (2011)
Hussein and Ahmed (2011)
Oria et al. (2013)
12 382 64.8 34.9–89.4
(continued)
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Results
Study characteristics and design
Twenty-nine studies conducted in 20 countries from SSA
examined participants’ comprehension of informed
consent information in clinical research on vaccines, tuber-
culosis treatment in HIV-infected patients, HIV prevention
trials, male circumcision scale-up, oral health, vitamin A
supplementation, immune correlates in paediatric age
group and genetic studies of hypertension (Table 2). The
number of study participants in the studies ranged from 36
to 5755. Of the studies, 17 interviewed participants close
to the time of consent (Abdool Karim et al. 1998; Leach
et al. 1999; Coulibaly-Traore et al. 2003; Pace et al. 2005;
Fairhead et al., 2006a,b; Krosin et al. 2006; Hill et al.
2008; Minnies et al. 2008; Taiwo & Kass 2009; Tekola
et al. 2009; Ellis et al. 2010; Hussein & Ahmed 2011;
Ciampa et al. 2012; Kiguba et al. 2012; Vreeman et al.
2012; Saidu et al. 2013); interviews were conducted
1–14 months after participants gave consent in six studies
(Joubert et al. 2003; Ekouevi et al. 2004; Moodley et al.
2005; Hill et al. 2008; Vallely et al. 2010; Ndebele et al.
2012) and longer than 14 months in two studies
(Oduro et al. 2008; Chaisson et al. 2011); pre- and post-
assessments were carried out in two studies (Preziosi et al.
1997; Oria et al. 2013), while baseline and repeated
assessments of understanding were carried out in another
two studies (Vallely et al. 2007; Chaisson et al. 2011). Six
studies interviewed the mothers of study children (Preziosi
et al. 1997; Leach et al. 1999; Minnies et al. 2008; Oduro
et al. 2008; Oria et al. 2013; Saidu et al. 2013); nine stud-
ies interviewed adult male and female participants (Joubert
et al. 2003; Ekouevi et al. 2004; Moodley et al. 2005;
Marshall et al. 2006; Hill et al. 2008; Tekola et al. 2009;
Vallely et al. 2010; Friedland et al., 2011a,b), seven inter-
viewed only female participants (Abdool Karim et al.
1998; Coulibaly-Traore et al. 2003; Joubert et al. 2003;
Vallely et al. 2010; Hussein & Ahmed 2011; Ciampa et al.
2012; Ndebele et al. 2012), two interviewed only male
participants (Friedland et al., 2011a,b) and five studies
interviewed both parents and adult participants (Molyneux
et al. 2004; Pace et al. 2005; Krosin et al. 2006; Ellis et al.
2010; Vreeman et al. 2012).
Measurement tools
Sixteen studies used questionnaires to assess participants’
comprehension (Abdool Karim et al. 1998; Joubert et al.
2003; Ekouevi et al. 2004; Moodley et al. 2005; Krosin
et al. 2006; Manafa et al. 2007; Minnies et al. 2008;
Oduro et al. 2008; Ellis et al. 2010; Chaisson et al.
2011; Hussein & Ahmed 2011; Ciampa et al. 2012;
Kiguba et al. 2012; Ndebele et al. 2012; Oria et al.
2013; Saidu et al. 2013); six employed in-depth qualita-
tive interviews (Leach et al. 1999; Coulibaly-Traore et al.
2003; Molyneux et al. 2004; Pace et al. 2005; Hill et al.
2008; Tekola et al. 2009) and five used both qualitative
and quantitative methods (Marshall et al. 2006; Taiwo
& Kass 2009; Vallely et al. 2010; Friedland et al.,
2011a,b) and two used community group discussions
Table 4 (Continued)
Domains Studies
Total
sample
size
Proportion
(%)
95%
CI
Study procedure (n = 13) Chaisson et al. (2011)
Saidu et al. (2013)
Oduro et al. (2008)
Ellis et al. (2010)
Manafa et al. (2007)
Taiwo and Kass (2009)
Kiguba et al. (2012)
Pace et al. (2005)
Friedland et al. (2011a)
Friedland et al. (2011b)
Abdool Karim et al. (1998)
Minnies et al. (2008)
Joubert et al. (2003)
6985 72.9 55.2–87.4
Table shows that about 50% of participants across various studies understood placebo, randomisation and risks, while higher propor-
tions (about 70%) understood benefits, blinding and study procedure.
636 © 2014 John Wiley & Sons Ltd
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(Preziosi et al. 1997; Vreeman et al. 2012). The majority
of the questionnaires used closed-ended response formats.
The questionnaires varied significantly in the number of
items, and the domains addressed by these items. The
authors indicated the number of question items in eight
studies (Moodley et al. 2005; Krosin et al. 2006; Mar-
shall et al. 2006; Minnies et al. 2008; Ellis et al. 2010;
Chaisson et al. 2011; Friedland et al., 2011a,b); the num-
ber ranged from 3- to 20-item quiz. The items in the
questionnaire could be classified into two broad domains:
generic and trial-specific questions (Joffe et al. 2001).
The generic questions focused on general aspects of
research such as confidentiality, compensation, rights of
withdrawal or refusal (Table 3), while the trial-specific
questions focused on individual research-related domains
such as study purpose, study rationale, study procedures,
medications, risks and adverse events (Table 4). A com-
plete questionnaire was included in the appendix in three
papers (Krosin et al. 2006; Minnies et al. 2008; Ellis
et al. 2010). Participants were assessed on several
domains of informed consent, while two studies (Tekola
et al. 2009; Vallely et al. 2010) focused only on partici-
pants’ understanding of therapeutic misconception. The
format adopted in the semistructured or in-depth inter-
views was not clearly discussed in most of the papers
except one study (Vallely et al. 2010) which used a stan-
dardised interview guide.
Development of measurement tools
Only four manuscripts (Krosin et al. 2006; Vallely et al.
2010; Ciampa et al. 2012; Ndebele et al. 2012) provided
an account of how the measurement instrument was
developed. One study (Taiwo & Kass 2009) mentioned
that the questionnaire was adapted from previously
developed questionnaires such as the Quality Question-
naire of Informed Consent and the Deaconess Informed
Consent Questionnaire. Another study (Ciampa et al.
2012) adapted and validated its questionnaire from the
Wide Range Achievement Test. Ten reported that they
translated and back-translated the questionnaires from
foreign languages to participants’ local languages (Joubert
et al. 2003; Moodley et al. 2005; Pace et al. 2005;
Krosin et al. 2006; Marshall et al. 2006; Oduro et al.
2008; Chaisson et al. 2011; Ciampa et al. 2012; Kiguba
et al. 2012; Ndebele et al. 2012). Significant linguistic
diversity made it costly and logistically challenging to
translate informed consent documents from English,
French or Portuguese into effective written versions of
several local languages of participants in each country
(Preziosi et al. 1997; Tekola et al. 2009; Chaisson et al.
2011; Ciampa et al. 2012; Ndebele et al. 2012).
In three studies, participants’ comprehension was
measured by the proportion of correct responses to the
question items (Krosin et al. 2006; Oduro et al. 2008;
Ellis et al. 2010), while other studies assessed proportions
of participants who gave correct responses to question-
naires and interviews (Joubert et al. 2003; Ekouevi et al.
2004; Moodley et al. 2005; Marshall et al. 2006). Addi-
tionally, terms such as ‘understanding’, ‘comprehension’,
‘knowledge’, ‘remembering’, ‘retention’, ‘recall, ‘aware-
ness’ or ‘recognition’ were used interchangeably without
clear definitions. Only one study (Minnies et al. 2008)
defined the outcome variables: recall as ‘success in select-
ing the correct answers in the question items’ and under-
standing as ‘correctness of interpretation of statements
presented in the question items’. There was also no
consensus on the time points to measure comprehension
as participants (Pace et al. 2005; Krosin et al. 2006;
Marshall et al. 2006; Sand et al. 2010; Friedland et al.,
2011a,b) were evaluated at different times.
Comprehension of informed consent information
This section focuses on the meta-analytic results on 21
studies (Abdool Karim et al. 1998; Joubert et al. 2003;
Ekouevi et al. 2004; Moodley et al. 2005; Pace et al.
2005; Krosin et al. 2006; Marshall et al. 2006; Manafa
et al. 2007; Minnies et al. 2008; Oduro et al. 2008;
fTaiwo & Kass 2009; Ellis et al. 2010; Vallely et al.
2010; Chaisson et al. 2011; Friedland et al., 2011a,b;
Hussein & Ahmed 2011; Kiguba et al. 2012; Ndebele
et al. 2012; Oria et al. 2013; Saidu et al. 2013) and com-
plementary narrative comparison of all eligible studies.
Study purpose. Meta-analytic results showed that 65% of
a total of 12 382 participants in 17 studies (Abdool Karim
et al. 1998; Joubert et al. 2003; Ekouevi et al. 2004; Pace
et al. 2005; Krosin et al. 2006; Marshall et al. 2006;
Manafa et al. 2007; Minnies et al. 2008; Taiwo & Kass
2009; Ellis et al. 2010; Chaisson et al. 2011; Friedland
et al., 2011a,b; Hussein & Ahmed 2011; Ndebele et al.
2012; Oria et al. 2013; Saidu et al. 2013) understood the
purpose of the studies they were involved in (95% CI 34.9–
89.4%). Furthermore, on descriptive comparison, compre-
hension of study purpose assessed in 18 studies (Preziosi
et al. 1997; Abdool Karim et al. 1998; Leach et al. 1999;
Coulibaly-Traore et al. 2003; Joubert et al. 2003; Ekouevi
et al. 2004; Molyneux et al. 2004; Moodley et al. 2005;
Pace et al. 2005; Krosin et al. 2006; Marshall et al. 2006;
Manafa et al. 2007; Hill et al. 2008; Taiwo & Kass 2009;
Chaisson et al. 2011; Ciampa et al. 2012; Kiguba et al.
2012; Saidu et al. 2013) was markedly high among
participants in southern Africa (Minnies et al. 2008;
© 2014 John Wiley & Sons Ltd 637
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Chaisson et al. 2011; Friedland et al., 2011a,b). This ran-
ged from 88% to 98.7%, while East and West African par-
ticipants had comprehension rates between 8% and 47%
(Joubert et al. 2003; Molyneux et al. 2004; Taiwo & Kass
2009; Kiguba et al. 2012). Most participants in countries
with poorer comprehension had a low level of education.
Endemicity of the conditions studies also explained the dis-
parities in the observed responses. For instance, there were
marked differences in comprehension of the causes, routes
of transmission and prevention of HIV by pregnant women
in Cote d’Ivoire and South Africa, with most participants in
Cote d’Ivoire demonstrating poor understanding of the
study rationale (Coulibaly-Traore et al. 2003; Ekouevi
et al. 2004). Similarly, poor comprehension was observed
in participants enrolled in an oral health study in Nigeria
(Taiwo & Kass 2009).
Voluntary participation. About 80% of 3679 participants
across eight studies (Abdool Karim et al. 1998; Joubert
et al. 2003; Moodley et al. 2005; Krosin et al. 2006;
Oduro et al. 2008; Taiwo & Kass 2009; Chaisson et al.
2011; Kiguba et al. 2012) demonstrated comprehension
about voluntariness towards participation (95% CI 39.0–
98.5%), with perceived medical benefit cited as a main
determinant (Leach et al. 1999; Pace et al. 2005; Oduro
et al. 2008). Inadequate access to health care and other
poor socio-economic factors in developing countries were
reported as strong motives for joining clinical trials (Preziosi
et al. 1997; Leach et al. 1999). Severity of diseases also con-
tributes to the sense of compulsion to participate. In a Ken-
yan study, only 4% of mothers of seriously ill children
agreed that participation was voluntary, while most partici-
pants believed that they would have been chased away if
they refused to join the study (Molyneux et al. 2004). In
contrast, 97% of mothers whose children were less seriously
sick in the same study reported voluntary participation dur-
ing admission; 14% spontaneously reported this on dis-
charge and 59% after prompting (Molyneux et al. 2004).
Right of withdrawal. Of 4183 participants across 13 stud-
ies (Abdool Karim et al. 1998; Joubert et al. 2003; Ekouevi
et al. 2004; Moodley et al. 2005; Pace et al. 2005; Krosin
et al. 2006; Marshall et al. 2006; Manafa et al. 2007;
Minnies et al. 2008; Oduro et al. 2008; Ellis et al. 2010;
Friedland et al., 2011a; Saidu et al. 2013), 57% under-
stood right of withdrawal (95% CI 33.3–78.6%). Further
descriptive comparison of findings in seven studies (Abdool
Karim et al. 1998; Ekouevi et al. 2004; Pace et al. 2005;
Krosin et al. 2006; Manafa et al. 2007; Oduro et al. 2008;
Ellis et al. 2010) showed that understanding of the right to
withdraw from a study was low among most study
participants across West African subregion. In a Malian
trial (Krosin et al. 2006), participants believed that leaving
before the end of the study would be disrespectful to the
investigators who might consequently deny them medical
benefits associated with participation. Their counterparts
from a South African (Abdool Karim et al. 1998) study
showed better comprehension of their rights to stop partici-
pation. Similar trends were observed for rights of refusal to
participate. Taiwo and Kass (2009) reported that social sta-
tus in the study community might positively influence a par-
ticipant to enrol in a study. One example was cited of a
highly educated community officer who enrolled in a trial
so as not to discourage other community members from
joining the trial. Participants in a Gambian study (Leach
et al. 1999) also expressed the fear of serious, unknown
side effects of an experimental vaccine as a major reason
for declining to enrol in the study.
Confidentiality. Meta-analytic results showed that 55%
of a total of 1775 participants in four studies (Minnies
et al. 2008; Oduro et al. 2008; Taiwo & Kass 2009; Saidu
et al. 2013) did not understand the concept of confidential-
ity. However, descriptive comparison showed a high level
of comprehension in two studies (Minnies et al. 2008;
Saidu et al. 2013), but in other two studies (Taiwo & Kass
2009; Kiguba et al. 2012), participants were not aware of
how their research records would be kept.
Compensation. Across three studies (Krosin et al. 2006;
Oduro et al. 2008; Chaisson et al. 2011) involving 2428
participants, 76% understood compensation (95% CI
39.0–98.5%). Understanding of compensation associated
with participation was largely dependent on how the
questions were framed and presented to the participants,
who generally considered personal benefit a high priority.
Participants in two studies (Oduro et al. 2008; Chaisson
et al. 2011) misunderstood reimbursement of transport
fares as payment for study participation.
Risks. About 51% of 3419 participants understood risks
involved in study participation (95% CI = 32.1–70.2%)
in 10 studies (Leach et al. 1999; Molyneux et al. 2004;
Pace et al. 2005; Krosin et al. 2006; Manafa et al. 2007;
Minnies et al. 2008; Taiwo & Kass 2009; Ellis et al.
2010; Chaisson et al. 2011; Kiguba et al. 2012). This
was found to be better among participants from southern
Africa (Minnies et al. 2008; Chaisson et al. 2011) than
among participants in West African studies (Krosin et al.
2006; Taiwo & Kass 2009).
Therapeutic misconception. Only 30% of 753 partici-
pants across five studies (Ekouevi et al. 2004; Moodley
et al. 2005; Krosin et al. 2006; Manafa et al. 2007; Tai-
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wo & Kass 2009) understood the concept of therapeutic
misconception. This occurs when participants believe that
the study is solely aimed at providing health care rather
than generating research data. It featured prominently
among West African participants (Ekouevi et al. 2004;
Krosin et al. 2006; Manafa et al. 2007; Taiwo & Kass
2009), while a South African study (Moodley et al.
2005) reported that a significant proportion of partici-
pants recognised they were participating in a research as
opposed to seeking medical care.
Randomisation and placebo. Of 1633 participants in four
studies (Moodley et al. 2005; Pace et al. 2005; Krosin et al.
2006; Ellis et al. 2010), 47% demonstrated understanding
about randomisation (95% CI = 13.9–80.9%). Similarly,
48% of 3946 participants in six studies (Moodley et al.
2005; Pace et al. 2005; Manafa et al. 2007; Vallely et al.
2010; Chaisson et al. 2011; Ndebele et al. 2012) had
understanding of placebo (95% CI 0.19.0–77.5%).
Descriptive comparison showed that methods employed in
explaining the concepts of randomisation and use of pla-
cebo during informed consent process influenced partici-
pants’ understanding. Malawian participants (Ndebele
et al. 2012) demonstrated good understanding of randomi-
sation when a locally designed narrative was used to illus-
trate the research terms. About 75–78% of these
participants comprehended randomisation and placebo,
while 10–19% of East and West African participants dem-
onstrated good understanding of the concepts (Leach et al.
1999; Pace et al. 2005; Hill et al. 2008).
Autonomy/decision-making. Seven studies (Leach et al.
1999; Coulibaly-Traore et al. 2003; Ekouevi et al. 2004;
Molyneux et al. 2004; Krosin et al. 2006; Friedland
et al., 2011a,b) assessed this concept. Ninety-nine per-
centage of Gambian participants (Leach et al. 1999) sub-
mitted that parents and village leaders were involved in
decision-making. Similar patterns were reported in East
and other West African studies (Ekouevi et al. 2004;
Molyneux et al. 2004; Krosin et al. 2006), while individ-
ual decision-making was common in southern African
countries (Friedland et al., 2011a,b).
Predictors of comprehension. In most studies reviewed
(Oduro et al. 2008; Taiwo & Kass 2009; Chaisson et al.
2011; Kiguba et al. 2012; Ndebele et al. 2012), demo-
graphic variables like age and literacy did not show statisti-
cal significance, but male sex was reported as the only
independent predictor of higher comprehension scores in
one study (Ellis et al. 2010). Conversely, primary educa-
tion and residence in urban areas were predictors of
understanding among women (Hill et al. 2008). Similarly,
another study (Krosin et al. 2006) reported higher compre-
hension scores in most urban participants than their rural
counterparts. Among Mozambican participants, numeracy
level was significantly associated with comprehension of
study purpose and this was independent of respondent’s
age, income, distance from the hospital and the language
of survey administration (Ciampa et al. 2012). Moodley
et al. (2005) also reported a positive linear correlation
between participants’ comprehension scores and their
mini-mental state examination scores.
Discussion
To our knowledge, this is the first comparison of partici-
pants’ comprehension of informed consent information in
studies conducted across SSA. Previous reviews have either
concentrated on informed consent comprehension in devel-
oped countries (Sand et al. 2010) or compared the quality
of informed consent between Western and developing
countries in Africa and Asia (Mandava et al. 2012).
Our review reveals that the methods used for assessing
participants’ comprehension differed significantly. Such
variations in methodology limited comparison of findings
and raise challenges about how to measure comprehen-
sion of informed consent information. Very few studies
(Ciampa et al. 2012; Ndebele et al. 2012) described the
format and justifications for deciding to use a set of ques-
tion items. A sizeable proportion of the tools were devel-
oped ad hoc for each study without following standard
guidelines of instrument development and validation.
We also identified a lack of a uniform definition of
comprehension as studies in the review used the term
‘comprehension’ to mean ‘understanding’ or ‘recall’ or
‘retention’ or ‘knowledge’. It is important to establish a
distinction between these terms as it would help in devel-
oping a uniform definition for the concept. This effort is
capable of providing an acceptable method for determin-
ing how an instrument can be constructed, implemented,
interpreted and applied to measure the concept (Spreitzer
& Sonenshein 2004).
The domains of informed consent assessed by the stud-
ies also vary considerably with little regard to the crucial
information that could engender comprehension. There is
a need to develop guidelines that define the most crucial
information relevant for comprehension of informed con-
sent in African research settings as well as the best way
this information should be communicated.
Most study participants in this review did not under-
stand the distinction between research participation and
seeking medical care. This concept of therapeutic miscon-
ception has been documented among participants in
resource poor settings where inadequate access to health
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care exists (Appelbaum et al. 1982; Preziosi et al. 1997).
This is due to a mix of heavy burden of disease, poor
access to health care, poor education, low literacy levels
and the overriding impact of illness, suffering and pov-
erty on decision-making. A National Bioethics Advisory
Commission reported that therapeutic misconception
does not imply that participants will most likely get ade-
quate clinical care during research, but subsists when
participants believe that the sole aim of clinical trials is
to provide treatment rather than collect data (NBAC
2001). Consequently, African researchers should strive to
harmonise the research of essential medicines with the
ethical requirements of making them accessible.
Improved access to such care could reduce vulnerability
and ultimately improve comprehension of African partici-
pants.
The time interval between informed consent process
and assessment of comprehension in most of the studies
was long, some more than 14 months after the trials
have ended. Given the background of low literacy among
participants, and not being familiar with research terms,
it is very unlikely that reliable inferences can be drawn
from assessments carried out after such long periods.
There are no existing guidelines on the timing of such
assessments as these are likely to be study or context
specific.
Availability of the questionnaires in local languages
was reported to aid participants’ understanding in few
countries (Chaisson et al. 2011; Ndebele et al. 2012).
However, this is not always possible as some African lan-
guages are spoken and do not have standardised writing
formats. Translations and back-translation of informed
consent documents are practically challenging in the
Gambia for this reason.
A major strength of this review is the combination of
meta-analytic results with the narrative comparison of
the findings. This provided a robust summary of the find-
ings on informed consent comprehension despite signifi-
cant disparities in methodologies and heterogeneity of the
data. Further contributing to this, we excluded partici-
pants in hypothetical studies so that our findings could
reflect true clinical research situations as much as possi-
ble. We also included studies where participants were leg-
ally and cognitively competent, to remove factors which
might confound our findings.
Limitations
Very few of the studies included in this review provided
adequate information on the instruments employed to
assess comprehension of informed consent. This did not
permit analysis of wordings of the questionnaires to
establish what the authors actually explored in their stud-
ies. Such analysis could have provided useful insights that
might have contributed to appropriate interpretations of
findings of the studies.
Also, findings of this review need to be cautiously inter-
preted because majority of the quantitative instruments
used in this review contained closed-ended questionnaires,
which are known to be an imperfect method of assessing
comprehension, because respondents could guess answers
correctly or provide socially desirable responses. This
could have over-estimated the comprehension levels,
thereby leading to inaccuracies in our findings. Studies
(OnvomahaTindana et al. 2006; Ndebele et al. 2012) have
shown that requesting participants to explain, using their
own words, their comprehension of study information may
truly manifest what participants understand.
It could also be inferred that studies in this review exam-
ined the ‘performance’ of participants, but apparently did
not evaluate the communication skills of the researchers
administering the consent; and this plays a key role for
comprehension. This may represent an asymmetry, where
researchers ask ‘why participants do not comprehend’ but
we do not ask ourselves ‘why are we not good at explain-
ing crucial information to our participants?’
Nevertheless, the representativeness of studies in this
review provides a comprehensive knowledge base for set-
ting research agenda and plans.
Conclusions
Our review confirmed the findings of previous reviews that
comprehension of informed consent in Africa settings varies
from country to country with relatively better comprehen-
sion among participants in southern Africa. Tools for mea-
suring participants’ comprehension are neither validated
nor standardised. To overcome potential pitfalls in effec-
tiveness of conventional informed consent procedures in
African research settings, it is crucial to engage a body of
knowledge on the development of clear guidelines to design
adequate tools for improving informed consent comprehen-
sion and maximise the voluntariness of the choice to partic-
ipate in clinical trials. Such tools should translate the
respect for fundamental ethical principles, by taking into
considerations local cultural values and constraints.
Furthermore, due to wide linguistic variability that
made effective translations of informed consent documents
to local languages challenging, appropriately developed
tools using orally interpreted procedure with non-verbal
support like video and animations may improve the com-
prehensibility of unfamiliar research concepts among
African participants. Experts who are familiar with the
local context and influence of communication and
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demographic factors on informed consent process need to
be involved in the design. This multidisciplinary approach
should harmonise local contextual and behavioural fac-
tors, including the expectations of the community, in
developing comprehensible consent tools.
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